¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive hypertrophic polyneuropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • progressive deafness
    ÁøÇ೭û
  • progressive diaphyseal dysplasia
    ÁøÇ༺»À¸öÅëÇü¼ºÀÌ»ó, ÁøÇ༺°ñ°£Çü¼ºÀÌ»ó
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive external ophthalmoplegia
    ÁøÇà¹Ù±ù´«±ÙÀ°¸¶ºñ
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é(»ö)Áú³úº´(Áõ)
  • progressive muscular dystrophy
    ÁøÇà±Ù(À°)µð½ºÆ®·ÎÇÇ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • progressive outer retinal necrosis
    ÁøÇ༺¿Ü¸Á¸·±«»ç
  • progressive pigmentary dermatosis
    ÁøÇà»ö¼ÒÇǺκ´
  • progressive resistance
    Á¡ÁõÀúÇ×
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´Áõ
  • familial progressive hearing loss
    °¡Á·ÁøÇ೭û
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • malignant progressive histiocytoma
    ¾Ç¼ºÁøÇàÁ¶Á÷±¸Á¾
  • progressive disseminated histoplasmosis
    ÁøÇàÆÄÁ¾È÷½ºÅäÇö󽺸¶Áõ
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½ÉÀå±ÙÀ°º´Èæ»öÁ¡Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é»öÁú³úÁõ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • progressive
    ÁøÇà-
  • progressive bulbar palsy
    ÁøÇà¼û³ú¸¶ºñ, ÁøÇ౸¸¶ºñ
  • progressive resistance
    Á¡ÁõÀúÇ×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº<ºñ´ë¼º>Æó°ñ°üÀýº´Áõ.
  • hypertrophic pyloric stenosis
    ºñÈļº À¯¹®ÇùÂø(ºñÈļºÀ¯¹®ÇùÂø).
  • hypertrophic rhinitis
    ºñÈÄ(¼º) ºñ¿°
  • hypertrophic salpingitis
    ºñÈļº ³­°ü¿°.
  • hypertrophic scar
    ºñÈļº ¹ÝÈç(¡­¹ÝÈç).
  • hypertrophic subaortic stenosis
    ºñÈļº(ºñ´ë¼º)´ëµ¿¸ÆÇÏ ÇùÂø.(¡­ÓÞÔÑØæù» úõó¸)
  • hypertrophic subaortic stenosis,idiopathic
    Ư¹ß¼º
  • hypertrophic type
    ºñ´ëÇü
  • hypertrophic vulvitis
    ºñ´ë¼º ¿ÜÀ½¿°(¡­èâëäæú).
  • hypertrophic zone
    ºñ´ëÃþ
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º °úÇü¼º °ñ°üÀýº´Áõ.
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º °ñ ´Ù°øÁõ(÷åÛ¡àõÍéÒýÍîñø), Ư¹ß¼º °ñ Á¶¼ÛÁõ(÷åÛ¡àõÍéðØáçñø), Ư¹ß¼º °úÇü¼º °ñ°üÀýº´Áõ.
  • idiopathic hypertrophic subaortic stenosis
    Ư¹ß¼º ºñÈļº ´ëµ¿¸ÆÆÇ ÇϺÎÇùÂø(Áõ).
  • idiopathic hypertrophic subaortic stenosis
    Ư¹ß¼ººñÈļº´ëµ¿¸ÆÆÇÇϺÎÇùÂø(¡­Ýþý§àõÓÞÔÑØæ÷ùù»Ý»úõó¸)
  • pharyngitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º) Àεο°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypertrophic cicatrix
    ºñÈļº ¹ÝÈç(¡­¹ÝÈç).
  • hypertrophic emphysema
    ºñ´ë¼º ±âÁ¾ (¡­Ñ¨ðþ).
  • hypertrophic emphysema
    ºñ´ë¼º ±âÁ¾ (¡­Ñ¨ðþ).
  • hypertrophic gastritis ³ª g. hypertrophica
    ºñÈļº À§¿°(Ýþý§àõêÖæú).
  • hypertrophic gingivitis ³ª g. hypertrophica
    Áõ½Ä¼º Ä¡Àº¿°(ñòãÖàõöÍó» æú).
  • hypertrophic gliosis
    ºñ´ë¼º ½Å°æ±³Áõ.
  • hypertrophic heart
    ºñ´ë½ÉÀå.
  • hypertrophic interstitial neuropathy
    ºñÈļº °£Áú¼º ½Å°æº´Áõ.
  • hypertrophic lupus erythematosus
    ºñÈļºÈ«¹Ý¼º³¶Ã¢
  • hypertrophic obstructive cardiomyopathy
    ºñÈļº Æó¼â¼º ½É±Ùº´Áõ.
  • hypertrophic obstructive cardiomyopathy
    ºñ´ë¼ºÆó¼â¼º½É±Ùº´Áõ(¡­øÍáðàõãýÐÉÜ»ñø)
  • hypertrophic obstructive cardiomyopathy
    ºñÈÄÇü Æó¼â¼º ½É±Ùº´Áõ.
  • hypertrophic ost(e)itis
    ºñ´ë¼º °ñ¿°.
  • hypertrophic osteoarthropathy
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº<ºñ´ë¼º> Æó °ñ°üÀýº´Áõ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AIDP acute idiopathic demyelinating polyneuropathy
CIPN chronic inflammatory polyneuropathy
CPN central parenteral nutrition; chronic polyneuropathy; chronic pyelonephritis
CR-DIP chronic relapsing demyelinating inflammatory polyneuropathy
DPN dermatosis papulosa nigra; diabetic polyneuropathy; diphosphopyridine nucleotide; disabling panscler...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
HCM Hypertrophic Cardiomyopathy
HOCM Hypertrophic Obstructive Cardiomyopathy
HNCM Hypertrophic non-obstructive cardiomyopathy
HOA Hypertrophic osteoarthropathy
HPOA Hypertrophic pulmonary osteoarthropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±Ù À§ÃàÁõ
  • progressive supranuclear palsy
    ÁøÇ༺ ÇÙ»ó ¸¶ºñ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • symmetrical progressive erythrokeratoderma
    ´ëμº ÁøÇ༺ È«¹Ý °¢ÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
hypertrophic interstitial neuropathy Sensorimotor neuropathy characterised pathologically by collections of Schwann cell processes arranged concentrically around one or more nerve fibres. No genetic factors are known in its aetiology.For hereditary types, see hereditary hypertrophic neuropathy.
(05 Mar 2000)
hypertrophic osteoarthropathy <radiology> Pulmonary, malignancy (bronchogenic carcinoma, lymphoma, metastasis), abscess, COPD / bronchiectasis, pleural, pleural fibroma (highest incidence of HOA, tho' rare itself), mesothelioma, cardiac, cyanotic congenital heart disease, GI, inflammatory disease (Crohn, UC), malabsorption (dysentery, lue, cirrhosis), ** causes symmetrical periosteal reaction
(12 Dec 1998)
hypertrophic pyloric stenosis <radiology> Not seen until 3 weeks, projectile vomiting, palpable olive in RUQ/epigastrium
(12 Dec 1998)
hypertrophic rhinitis Chronic rhinitis with permanent thickening of the mucous membrane.
(05 Mar 2000)
hypertrophic rosacea A manifestation of severe acne rosacea resulting in significant enlargement of the nose and occurring primarily in men. It is caused by hypertrophy of the sebaceous glands and surrounding connective tissue. The nose is reddened and marked with numerous telangiectasias.
(12 Dec 1998)
hypertrophic scar An elevated scar resembling a keloid but which does not spread into surrounding tissues, is rarely painful, and regresses spontaneously; collagen bundles run parallel to the skin surface.
(05 Mar 2000)
idiopathic hypertrophic subaortic stenosis <cardiology> A congenital heart disease that results in abnormal thickening of the ventricular septum and left ventricular wall. Enlargement of the ventricular septum can result in ventricular outflow obstruction (subaortic stenosis) and eventual cardiomyopathy.
(27 Sep 1997)
osteoarthropathy, primary hypertrophic A conditioned chiefly characterised by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, seborrhoea, hyperhidrosis, periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. It is believed to be inherited as an autosomal dominant trait.
(12 Dec 1998)
osteoarthropathy, secondary hypertrophic Symmetrical osteitis of the four limbs, chiefly localised to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart.
(12 Dec 1998)
familial hypertrophic cardiomyopathy Familial occurrence of hypertrophic cardiomyopathy exhibiting an autosomal dominant pattern of inheritance. Familial cardiomyopathy of various kinds occurs with autosomal dominant inheritance. There is also an asymmetrical form affecting the ventricles and the interventricular septum.
(05 Mar 2000)
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
bovine progressive degenerative myeloencephalopathy A familiar myeloencephalopathy of brown Swiss cattle characterised by bilateral hindleg weakness and ataxia and deficient proprioceptive reflexes.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
chronic progressive chorea A progressive disorder usually beginning in young to middle age, consisting of a triad of choreoathetosis, dementia, and autosomal dominant inheritance with complete penetrance. Bilateral marked wasting of the putamen and the head of the caudate nucleus is characteristic.
Synonym: chronic progressive chorea, degenerative chorea, hereditary chorea, Huntington's disease.
(05 Mar 2000)
chronic progressive external ophthalmoplegia A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á